These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 2918944

  • 1. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
    Weiss LG, Danielson BG, Fellström B, Wikström B.
    Nephron; 1989; 51(3):325-9. PubMed ID: 2918944
    [Abstract] [Full Text] [Related]

  • 2. Aluminum removal in uremic patients after desferrioxamine infusion: is hemofiltration more effective than hemodialysis?
    Winterberg B, Bertram HP.
    Nephron; 1990; 54(2):179. PubMed ID: 2314528
    [No Abstract] [Full Text] [Related]

  • 3. Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients.
    McCarthy JT, Milliner DS, Schmidt DF, Schniepp BJ, Kurtz SB, Johnson WJ.
    Kidney Int; 1988 Dec; 34(6):804-8. PubMed ID: 3210542
    [Abstract] [Full Text] [Related]

  • 4. Clinical aspects and applications of hemofiltration.
    Weiss LG.
    Scand J Urol Nephrol Suppl; 1989 Dec; 118():1-64. PubMed ID: 2785286
    [Abstract] [Full Text] [Related]

  • 5. Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
    Delmez J, Weerts C, Lewis-Finch J, Windus D, Slatopolsky E.
    Am J Kidney Dis; 1989 Apr; 13(4):308-11. PubMed ID: 2705449
    [Abstract] [Full Text] [Related]

  • 6. Deferoxamine and aluminum clearance in pediatric hemodialysis patients.
    Ogborn MR, Dorcas VC, Crocker JF.
    Pediatr Nephrol; 1991 Jan; 5(1):62-4. PubMed ID: 2025542
    [Abstract] [Full Text] [Related]

  • 7. Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis.
    Vasilakakis DM, D'Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME.
    Kidney Int; 1992 May; 41(5):1400-7. PubMed ID: 1614055
    [Abstract] [Full Text] [Related]

  • 8. Combined high-efficiency hemodialysis and charcoal hemoperfusion in severe N-acetylprocainamide intoxication.
    Kar PM, Kellner K, Ing TS, Leehey DJ.
    Am J Kidney Dis; 1992 Oct; 20(4):403-6. PubMed ID: 1384320
    [Abstract] [Full Text] [Related]

  • 9. Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis.
    Chang TM, Barre P.
    Lancet; 1983 Nov 05; 2(8358):1051-3. PubMed ID: 6138600
    [Abstract] [Full Text] [Related]

  • 10. Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia.
    Winchester JF, Ratcliffe JG, Carlyle E, Kennedy AC.
    Kidney Int; 1978 Jul 05; 14(1):74-81. PubMed ID: 682427
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of the effectiveness of hemodialysis and hemofiltration in the removal of aluminum from the body].
    Sulková S, Laurincová Z, Pancírová J, Komonová D, Válek A.
    Cas Lek Cesk; 1990 Aug 10; 129(32):998-1001. PubMed ID: 2208242
    [Abstract] [Full Text] [Related]

  • 12. Removal of chelated aluminium during haemodialysis using polysulphone high-flux dialysers.
    Aarseth HP, Ganss R.
    Nephrol Dial Transplant; 1990 Aug 10; 5(11):942-4. PubMed ID: 2127830
    [Abstract] [Full Text] [Related]

  • 13. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G, Albano V, Tancredi M, Daniele M, Pignatelli F.
    Biomater Artif Cells Artif Organs; 1987 Aug 10; 15(1):175-81. PubMed ID: 3449135
    [Abstract] [Full Text] [Related]

  • 14. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
    Válek A, Sulková S, Laurinová Z.
    Ter Arkh; 1991 Aug 10; 63(6):89-93. PubMed ID: 1948757
    [No Abstract] [Full Text] [Related]

  • 15. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 16. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S, Feliciangeli G, Colì L, Prandini R, Bonomini V.
    Contrib Nephrol; 1982 Jun 14; 29():123-32. PubMed ID: 6804167
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a new coated charcoal for hemoperfusion in uremia.
    Stefoni S, Feliciangeli G, Coli L, Bonomini V.
    Int J Artif Organs; 1979 Nov 14; 2(6):320-3. PubMed ID: 511374
    [Abstract] [Full Text] [Related]

  • 18. Improvement of continuous arteriovenous hemofiltration (CAVH) and hemofiltration (HF) efficiency by adding hemoperfusion (HP).
    Marangoni R, Civardi F, Masi F, Avanzi C, Savino R, Manfredi A, Cimino R.
    Biomater Artif Cells Artif Organs; 1990 Nov 14; 18(4):541-8. PubMed ID: 2285819
    [Abstract] [Full Text] [Related]

  • 19. Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results.
    Stefoni S, Colì L, Feliciangeli G, Scolari MP, Bonomini V.
    Int J Artif Organs; 1986 Sep 14; 9(5):297-300. PubMed ID: 3781660
    [Abstract] [Full Text] [Related]

  • 20. Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.
    Pizzella KM, Moore MC, Schultz RW, Walshe J, Schentag JJ.
    Ther Drug Monit; 1980 Sep 14; 2(3):273-81. PubMed ID: 7222181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.